Patients with severe COVID-19 exhibit substantial immune changes including lymphopenia and increased blood levels of inflammatory biomarkers such as C-Reactive Protein (CRP), IL-1β, TNF-α, IL-8, and IL-64–8. The gene discussed is CRP; the disease is lymphopenia.